Bio
Mr. Horan joined Slater in January 2002 as Executive Director of the Slater Center for Biomedical Technologies (“Slater Biomed”). In March 2005, Slater Biomed merged with four other entities comprising the Slater Program and was re-named the Slater Technology Fund. Effective with the merger, Mr. Horan was appointed Senior Managing Director. Mr. Horan began his career in the investment banking business in 1980, when he joined the Capital Markets Group of BankAmerica, San Francisco, CA. In 1986, Mr. Horan joined the venture capital firm of Johnston Associates in Princeton, NJ, one of the original seed stage investors in the field of biotechnology and life sciences. In 1998, Mr. Horan founded Sachem Ventures LLC, an independent seed stage venture development firm which focused in life science and healthcare markets. During his tenure in the venture capital business, Mr. Horan has served as CEO of several of his portfolio companies, including: Immunicon Corp. (NASDAQ: IMMC), a Philadelphia-based developer of cellular diagnostic systems, where he was CEO from 1989-1991; Praelux Corp. (acquired by GE Amersham), a Princeton-based firm developing advanced technology platforms for drug discovery, where he was CEO from 1992-1997; and Medical Metrix Systems Inc. (acquired by Altaris Health Partners, the private equity arm of AIG), a medical imaging business based in Hanover, NH, where he was CEO from 1998-1999. Mr. Horan received his A.B. from Dartmouth College in 1976 and an M.B.A. from the Tuck School at Dartmouth in 1980.
Career
|
Slater Technology FundEmail: [email protected] |